Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition.
Brittani R PriceTiffany L SudduthErica M WeekmanSherika JohnsonDanielle HawthorneAbigail WoolumsDonna M WilcockPublished in: Journal of neuroinflammation (2020)
These findings indicate that Trem2 activators may be effective for the treatment of AD and possibly other neurodegenerative disorders.